Medication info
Baitab Tablet 10/10 mg

Baitab Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
GENEWON SCIENCE Co., Ltd.
Appearance
White to light yellow, double-convex, rectangular tablet.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201601734 · Approved 2016.03.31 · Insurance code 671704990

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Ingredients

Manufacturer
GENEWON SCIENCE Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular diseases due to hypercholesterolemia.
View approved original text

This medication is used as an adjunct to diet to lower total cholesterol and LDL cholesterol levels, ApoB protein, and triglycerides in patients with primary hypercholesterolemia, particularly in those with heterozygous familial and non-familial hypercholesterolemia as well as mixed hyperlipidemia. Additionally, it is used in patients with homozygous familial hypercholesterolemia either as an adjunct to other lipid-lowering therapies or when other treatments are ineffective. This medication is applied in conjunction with a diet that includes restrictions on saturated fat and cholesterol intake, and is given when diet alone is insufficiently effective. Prior to use, secondary causes such as diabetes and hypothyroidism should be identified and treated if necessary, and continuous lipid level monitoring is important. This medication safely and effectively improves total cholesterol and bad cholesterol levels to reduce the risk of vascular diseases associated with hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.

Precautions

This medication can cause serious muscle-related side effects such as myopathy or rhabdomyolysis, so if muscle pain or weakness occurs, it is important to consult a doctor immediately. This medication should not be used in patients with certain diseases or allergies to medications, patients with active liver disease, or in women who are pregnant or breastfeeding. Particularly, patients with compromised liver function or abnormally elevated liver enzyme levels should use this medication with caution and undergo regular liver function tests. This medication may interact with other drugs; therefore, patients must inform their healthcare provider of any other medications they are currently taking, especially with certain antibiotics, antifungals, immunosuppressants, and some cardiovascular drugs. During treatment with this medication, if unexplained muscle pain, tenderness, or weakness occurs, it is essential to stop taking it immediately and inform a doctor. Women planning to become pregnant or who may be pregnant should not take this medication, and if pregnancy is confirmed, it should be stopped immediately. Women who are breastfeeding should also discontinue breastfeeding if taking this medication, and use in children or adolescents should be approached with caution as safety and efficacy have not been fully established. Elderly patients require special caution, and since this medication can elevate blood sugar levels, those at risk of diabetes should regularly monitor their blood glucose levels. In case of overdose, there is no specific antidote, so symptomatic treatment will be provided. While taking this medication, it is recommended to avoid grapefruit juice, and regular blood tests should be conducted to monitor liver function and muscle status.

Side effects

Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory disturbances, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic symptoms accompanying drug reactions, erythema multiforme, liver damage, muscle weakness, cataracts, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, taste disturbances, extraocular muscle disorders, facial paresis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory impairment, forgetfulness, amnesia, memory disorders, confusion, interstitial lung disease, lupus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant liver necrosis, liver cancer, liver failure, alopecia, various skin changes, lichenoid drug eruption, gynecomastia, decreased libido, sexual dysfunction, ophthalmoplegia, anemia, elevated aminotransferase levels, elevated ALP, elevated gamma-GT, elevated bilirubin levels, thyroid dysfunction, increased HbA1c, elevated fasting blood sugar levels, edema, thirst, facial edema, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is crucial to maintain the storage temperature between 1 and 30 degrees Celsius to keep the medication effective and stable for a long period.

Appearance and packaging

Appearance

White to light yellow, double-convex, rectangular tablet.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.